Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516489 · ClinicalTrials.gov registry record · Phase 1
Improving Fecal Occult Blood Test Completion Rates Among Veterans
A Phase 1 study, sponsored by Corporal Michael J. Crescenz VA Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 1,549
- Enrollment target
NCT01516489 is a Phase 1 study that has completed, run by Corporal Michael J. Crescenz VA Medical Center. The registered enrollment target is 1,549 participants.
The verdict
NCT01516489, a Phase 1 study, has completed, sponsored by Corporal Michael J. Crescenz VA Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1,549 participants
- Enrollment target
Study Summary
This is a 4-arm cluster randomized controlled trial to evaluate whether patient financial incentives directly integrated into primary care can improve fecal occult blood test (FOBT) completion rates. We will recruit primary care patients at the Philadelphia Veterans Affairs Medical Center (PVAMC) in 2 stages. In stage 1, we hypothesize that, compared to usual care, $5, $10, $20 incentives will each lead to a statistically significant increase in the rate of FOBT completion. We also hypothesize that there will be a direct dose-response relationship between the incentive amount and rates of FOBT completion. In stage 2, we hypothesize that a lottery-based incentive and a raffle-based incentive will both lead to a statistically significant increase in the rate of FOBT completion compared to a fixed payment incentive with an equivalent dollar per patient value.
Interventions
- BEHAVIORAL Stage 1
- BEHAVIORAL Stage 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,549 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01516489
The ClinicalTrials.gov registry entry for NCT01516489 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1,549 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corporal Michael J. Crescenz VA Medical Center, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stage 1 is the first listed.
NCT01516489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01516489 about?
NCT01516489 is a clinical study titled "Improving Fecal Occult Blood Test Completion Rates Among Veterans". This is a 4-arm cluster randomized controlled trial to evaluate whether patient financial incentives directly integrated into primary care can improve fecal occult blood test (FOBT) completion rates. We will recruit primary care patients at the Philadelphia Veterans Affairs Medical Center (PVAMC) in...
What is the current status of trial NCT01516489?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1,549 participants. The study started on 2012-02. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01516489?
The interventions under investigation include: Stage 1 (BEHAVIORAL), Stage 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT01516489?
This trial is sponsored by Corporal Michael J. Crescenz VA Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.